A Study of HLX42 in Advanced/Metastatic Solid Tumors

Clinical trial NCT06210815 · RECRUITING

Trial details

NCT number: NCT06210815
Sponsor: Shanghai Henlius Biotech
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor and NSCLC

Start date: 2024-03-14
Primary completion: 2026-09-02
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.